There is an established early premotor-dysfunction phase of PD (37) to which non-motor clinical variables, notably olfactory acuity and RBD, as well CSF biomarkers (e.g., α-synuclein) have demonstrated early PD stage detection sensitivity (38–43). Here, SNCA is linked to Parkinson disease.